|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.22 USD | +1.84% |
|
+12.45% | +16.20% |
| 05-11 | TD Cowen Adjusts Price Target on CVS Health to $110 From $105 | MT |
| 05-07 | CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says | MT |
Company Valuation: CVS Health Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 136,274 | 122,449 | 101,613 | 56,490 | 100,742 | 117,666 | - | - |
| Change | - | -10.15% | -17.02% | -44.41% | 78.34% | 16.8% | - | - |
| Enterprise Value (EV) 1 | 179,925 | 160,658 | 151,768 | 111,767 | 154,714 | 173,808 | 170,329 | 168,357 |
| Change | - | -10.71% | -5.53% | -26.36% | 38.43% | 12.34% | -2% | -1.16% |
| P/E ratio | 17.3x | 29.7x | 12.2x | 12.3x | 57.1x | 15x | 13x | 11.3x |
| PBR | 1.81x | 1.71x | 1.33x | 0.75x | 1.34x | 1.48x | 1.4x | 1.3x |
| PEG | - | -0.6x | 0x | -0.3x | -0.9x | 0x | 0.8x | 0.8x |
| Capitalization / Revenue | 0.47x | 0.38x | 0.28x | 0.15x | 0.25x | 0.29x | 0.28x | 0.26x |
| EV / Revenue | 0.62x | 0.5x | 0.42x | 0.3x | 0.38x | 0.43x | 0.4x | 0.38x |
| EV / EBITDA | 9.2x | 8.04x | 7.59x | 7.68x | 9.06x | 9.41x | 8.32x | 7.37x |
| EV / EBIT | 10.4x | 9.16x | 8.66x | 9.33x | 10.7x | 11.1x | 9.83x | 8.76x |
| EV / FCF | 11.4x | 11.9x | 14.6x | 17.7x | 19.8x | 23.9x | 18.4x | 16.1x |
| FCF Yield | 8.75% | 8.37% | 6.85% | 5.66% | 5.05% | 4.18% | 5.44% | 6.19% |
| Dividend per Share 2 | 2 | 2.2 | 2.42 | 2.66 | - | 2.64 | 2.746 | 2.941 |
| Rate of return | 1.94% | 2.36% | 3.06% | 5.93% | - | 2.86% | 2.98% | 3.19% |
| EPS 2 | 5.95 | 3.14 | 6.47 | 3.66 | 1.39 | 6.134 | 7.12 | 8.161 |
| Distribution rate | 33.6% | 70.1% | 37.4% | 72.7% | - | 43% | 38.6% | 36% |
| Net sales 1 | 292,111 | 322,467 | 357,776 | 372,809 | 402,067 | 408,400 | 424,613 | 445,497 |
| EBITDA 1 | 19,565 | 19,971 | 19,995 | 14,548 | 17,073 | 18,480 | 20,475 | 22,838 |
| EBIT 1 | 17,312 | 17,532 | 17,534 | 11,976 | 14,443 | 15,619 | 17,322 | 19,219 |
| Net income 1 | 7,910 | 4,149 | 8,344 | 4,614 | 1,768 | 7,855 | 9,155 | 10,202 |
| Net Debt 1 | 43,651 | 38,209 | 50,155 | 55,277 | 53,972 | 56,142 | 52,663 | 50,691 |
| Reference price 2 | 103.16 | 93.19 | 78.96 | 44.89 | 79.36 | 92.22 | 92.22 | 92.22 |
| Nbr of stocks (in thousands) | 1,321,000 | 1,313,967 | 1,286,897 | 1,258,408 | 1,269,432 | 1,275,927 | - | - |
| Announcement Date | 09/02/22 | 08/02/23 | 07/02/24 | 12/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 14.81x | 0.42x | 9.29x | 2.92% | 116B | ||
| 14.36x | 1.83x | 9x | 0.72% | 96.54B | ||
| 12.21x | 1.41x | 8.7x | 2.8% | 27.15B | ||
| 30.42x | 5.69x | 23.32x | 2.39% | 21.28B | ||
| 18.24x | 1.73x | 9.97x | 1.15% | 20.84B | ||
| 19.45x | 2.17x | 10.94x | 1.71% | 20.74B | ||
| 16.56x | 1.55x | 8.04x | 5.14% | 17.2B | ||
| 7.56x | 1.2x | 5.68x | -.--% | 16.4B | ||
| 13.55x | 1.68x | 8.05x | 0.84% | 12.75B | ||
| 12.5x | 0.97x | 5.4x | 3.82% | 11.8B | ||
| Average | 15.97x | 1.86x | 9.84x | 2.15% | 36.03B | |
| Weighted average by Cap. | 15.52x | 1.51x | 9.74x | 2.05% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- CVS Stock
- Valuation CVS Health Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















